Published September 17, 2026 · Category: News

Overview

Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price

Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the NHS after negotiations over its cost proved successful.

Details

About 1,000 women a year with HER2-low advanced breast cancer will be able to obtain Enhertu from Thursday after ministers and the drug’s makers struck a deal on its price.

Continue reading...

Source

Originally published at www.theguardian.com.

Related Articles